{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:00:20Z","timestamp":1763024420040,"version":"3.45.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017577","name":"Basic Public Welfare Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["Basic Public Welfare Research Program of Zhejiang Province [No. LGF22H030017]"],"award-info":[{"award-number":["Basic Public Welfare Research Program of Zhejiang Province [No. LGF22H030017]"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Medical and Health Technology Project","award":["No. 2022KY259"],"award-info":[{"award-number":["No. 2022KY259"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04275-2","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:57:37Z","timestamp":1763024257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BIGH3 as a potential biomarker for fibrosis in metabolic dysfunction-associated steatotic liver disease: insights from mouse and human studies"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhenjie","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Zhuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinlan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9434-897X","authenticated-orcid":false,"given":"Junping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"4","key":"4275_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"key":"4275_CR2","doi-asserted-by":"publisher","unstructured":"Paik JM, Henry L, Younossi Y, Ong J, Alqahtani S, Younossi ZM. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019. Hepatol Commun. 2023;7(10):e0251. https:\/\/doi.org\/10.1097\/HC9.0000000000000251.","DOI":"10.1097\/HC9.0000000000000251"},{"issue":"1","key":"4275_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4275_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389-97 e10.","journal-title":"Gastroenterology"},{"issue":"5","key":"4275_CR5","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65(5):1557\u201365.","journal-title":"Hepatology"},{"issue":"10","key":"4275_CR6","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.cgh.2023.01.006","volume":"21","author":"L de Avila","year":"2023","unstructured":"de Avila L, Henry L, Paik JM, Ijaz N, Weinstein AA, Younossi ZM. Nonalcoholic fatty liver disease is independently associated with higher all-cause and cause-specific mortality. Clin Gastroenterol Hepatol. 2023;21(10):2588-2596 e3.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"4275_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1053\/j.gastro.2021.10.051","volume":"162","author":"R Loomba","year":"2022","unstructured":"Loomba R, Ratziu V, Harrison SA, N.C.T.D.I.W. Group. Expert panel review to compare FDA and EMA guidance on drug development and endpoints in nonalcoholic steatohepatitis. Gastroenterology. 2022;162(3):680\u20138.","journal-title":"Gastroenterology"},{"key":"4275_CR8","doi-asserted-by":"publisher","unstructured":"Goodman ZD. Chapter 7 Hepatic Histopathology. Eugene R. Schiff MD M, FRCP, Willis C. Maddrey MD, MACP, editors. Schiff's Diseases of the Liver (11th ed). 2011. p. 152-215. https:\/\/doi.org\/10.1002\/9781119950509.","DOI":"10.1002\/9781119950509"},{"issue":"1","key":"4275_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17(1):156-163 e2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"4275_CR10","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"3","key":"4275_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","volume":"150","author":"K Imajo","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150(3):626-637 e7.","journal-title":"Gastroenterology"},{"issue":"6","key":"4275_CR12","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","volume":"127","author":"WM Rosenberg","year":"2004","unstructured":"Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology. 2004;127(6):1704\u201313.","journal-title":"Gastroenterology"},{"issue":"3","key":"4275_CR13","first-page":"303","volume":"5","author":"MJ Nielsen","year":"2013","unstructured":"Nielsen MJ, Nedergaard AF, Sun S, Veidal SS, Larsen L, Zheng Q, et al. The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters. Am J Transl Res. 2013;5(3):303\u201315.","journal-title":"Am J Transl Res"},{"issue":"2","key":"4275_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, et al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41(2):261\u201370.","journal-title":"Liver Int"},{"issue":"2","key":"4275_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/MCG.0000000000001284","volume":"54","author":"M Balakrishnan","year":"2020","unstructured":"Balakrishnan M, Loomba R. The role of noninvasive tests for differentiating NASH from NAFL and diagnosing advanced fibrosis among patients with NAFLD. J Clin Gastroenterol. 2020;54(2):107\u201313.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"4275_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12876-022-02290-1","volume":"22","author":"A Sugiyama","year":"2022","unstructured":"Sugiyama A, Kurisu A, E B, Ouoba S, Ko K, Rakhimov A, et al. Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups. BMC Gastroenterol. 2022;22(1):241.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"4275_CR17","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/hep.30842","volume":"70","author":"QM Anstee","year":"2019","unstructured":"Anstee QM, Lawitz EJ, Alkhouri N, Wong VWS, Romero-Gomez M, Okanoue T, et al. Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the STELLAR trials. Hepatology. 2019;70(5):1521\u201330.","journal-title":"Hepatology"},{"issue":"6","key":"4275_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321.","journal-title":"Hepatology"},{"issue":"2","key":"4275_CR19","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.3346\/jkms.2019.34.e14","volume":"34","author":"YJ Chae","year":"2019","unstructured":"Chae YJ, Jun DW, Saeed WK, Kang HT, Oh JH, Lee SM, et al. Feasibility and stability of liver biopsy before treatment for preclinical nonalcoholic fatty liver studies. J Korean Med Sci. 2019;34(2):e14.","journal-title":"J Korean Med Sci"},{"key":"4275_CR20","doi-asserted-by":"publisher","first-page":"170842","DOI":"10.1016\/j.peptides.2022.170842","volume":"155","author":"K Yang","year":"2022","unstructured":"Yang K, Huang N, Sun J, Dai W, Chen M, Zeng J. Transforming growth factor-beta induced protein regulates pulmonary fibrosis via the G-protein signalling modulator 2 \/Snail axis. Peptides. 2022;155:170842.","journal-title":"Peptides"},{"issue":"1","key":"4275_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jacbts.2023.08.005","volume":"9","author":"ML Bochenek","year":"2024","unstructured":"Bochenek ML, Saar K, Nazari-Jahantigh M, Gogiraju R, Wiedenroth CB, Munzel T, et al. Endothelial overexpression of TGF-beta-induced protein impairs venous thrombus resolution: possible role in CTEPH. JACC Basic Transl Sci. 2024;9(1):100\u201316.","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"4275_CR22","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1039\/C3MB70474B","volume":"10","author":"YY Lu","year":"2014","unstructured":"Lu YY, Chen QL, Guan Y, Guo ZZ, Zhang H, Zhang W, et al. Transcriptional profiling and co-expression network analysis identifies potential biomarkers to differentiate chronic hepatitis B and the caused cirrhosis. Mol Biosyst. 2014;10(5):1117\u201325.","journal-title":"Mol Biosyst"},{"issue":"4","key":"4275_CR23","doi-asserted-by":"publisher","first-page":"e0123311","DOI":"10.1371\/journal.pone.0123311","volume":"10","author":"ML Decaris","year":"2015","unstructured":"Decaris ML, Emson CL, Li K, Gatmaitan M, Luo F, Cattin J, et al. Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease. PLoS ONE. 2015;10(4):e0123311.","journal-title":"PLoS ONE"},{"issue":"1","key":"4275_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12964-024-01720-9","volume":"22","author":"Q He","year":"2024","unstructured":"He Q, He W, Dong H, Guo Y, Yuan G, Shi X, et al. Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease. Cell Commun Signal. 2024;22(1):346.","journal-title":"Cell Commun Signal"},{"key":"4275_CR25","doi-asserted-by":"crossref","unstructured":"Younesi FS, Miller AE, Barker TH, Rossi FMV, Hinz B. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis. Nat Rev Mol Cell Biol. 2024;25(8):617\u201358.","DOI":"10.1038\/s41580-024-00716-0"},{"key":"4275_CR26","doi-asserted-by":"crossref","unstructured":"Yang W, He H, Wang T, Su N, Zhang F, Jiang K, Zhu J, Zhang C, Niu K, Wang L, Yuan X, Liu N, Li L, Wei W, Hu J. Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis. Hepatology. 2021;74(5):2774-90.","DOI":"10.1002\/hep.31987"},{"issue":"7","key":"4275_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/dna.1992.11.511","volume":"11","author":"J Skonier","year":"1992","unstructured":"Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 1992;11(7):511\u201322.","journal-title":"DNA Cell Biol"},{"issue":"7","key":"4275_CR28","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","volume":"158","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Tabas I, Pajvani UB. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology. 2020;158(7):1913\u201328.","journal-title":"Gastroenterology"},{"key":"4275_CR29","doi-asserted-by":"publisher","unstructured":"Krzistetzko J, G\u00e9raud C, Dormann C, Riedel A, Leibing T. Association of differentially altered liver fibrosis with deposition of TGFBi in Stabilin-deficient mice. Int J Mol Sci. 2023;24(13):10969. https:\/\/doi.org\/10.3390\/ijms241310969.","DOI":"10.3390\/ijms241310969"},{"issue":"3","key":"4275_CR30","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188793","volume":"15","author":"L Niu","year":"2019","unstructured":"Niu L, Geyer PE, Wewer Albrechtsen NJ, Gluud LL, Santos A, Doll S, et al. Plasma proteome profiling discovers novel proteins associated with nonalcoholic fatty liver disease. Mol Syst Biol. 2019;15(3):e8793.","journal-title":"Mol Syst Biol"},{"key":"4275_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.117462","volume":"390","author":"N Hukerikar","year":"2024","unstructured":"Hukerikar N, Hingorani AD, Asselbergs FW, Finan C, Schmidt AF. Prioritising genetic findings for drug target identification and validation. Atherosclerosis. 2024;390:117462.","journal-title":"Atherosclerosis"},{"issue":"2","key":"4275_CR32","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3138\/canlivj-2024-0063","volume":"8","author":"C Bera","year":"2025","unstructured":"Bera C, Hamdan-Perez N, Kosick HM, Shengir M, Sebastiani G, Patel K. Validation of FIB-4 for the diagnosis of liver cirrhosis in metabolic dysfunction-associated steatotic liver disease. Can Liver J. 2025;8(2):280\u20133.","journal-title":"Can Liver J"},{"issue":"2","key":"4275_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cld.2023.01.022","volume":"27","author":"L Henry","year":"2023","unstructured":"Henry L, Eberly KE, Shah D, Kumar A, Younossi ZM. Noninvasive tests used in risk stratification of patients with nonalcoholic fatty liver disease. Clin Liver Dis. 2023;27(2):373\u201395.","journal-title":"Clin Liver Dis"},{"key":"4275_CR34","doi-asserted-by":"publisher","unstructured":"Stefano JT, Guedes LV, de Souza AAA, Vanni DS, Alves VAF, Carrilho FJ, et al. Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease. Ann Hepatol. 2021;20:100253. https:\/\/doi.org\/10.1016\/j.aohep.2020.08.070.","DOI":"10.1016\/j.aohep.2020.08.070"},{"issue":"6","key":"4275_CR35","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/ijc.32247","volume":"145","author":"B Costanza","year":"2019","unstructured":"Costanza B, Rademaker G, Tiamiou A, De Tullio P, Leenders J, Blomme A, et al. Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. Int J Cancer. 2019;145(6):1570\u201384.","journal-title":"Int J Cancer"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04275-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:57:41Z","timestamp":1763024261000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04275-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4275"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04275-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Affiliated Hospital of Hangzhou Normal University (2020 (lun 02) KS-027) and the study protocol was in accordance with the ethical guidelines of the Declaration of Helsinki Principles of 1975.All patients provided written informed consent.All animal experiments were approved by the Animal Care and Use Committee of Hangzhou Normal University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"805"}}